| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President &CEO
1 company
Stonehouse Jon P is a Chief Executive Officer at BIOCRYST PHARMACEUTICALS INC. Recent SEC Form 4 filings include 2 buys and 7 sells.
Estimated insider holdings value: $11.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Buy | 30,000 | $5.55 | $166,500.00 | +2.7% | +37.3% | +78.7% | |
| Feb 1, 2023 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sale+OE | 100,000 | $10.38 | $1,038,000.00 | -9.0% | -29.9% | -49.8% | |
| Dec 15, 2022 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sell | 14,100 | $10.90 | $153,690.00 | -1.6% | -22.6% | -42.7% | |
| Dec 2, 2022 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sale+OE | 297,573 | $12.94 | $3,851,917.80 | -14.2% | -30.7% | -51.9% | |
| Jan 11, 2022 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sale+OE | 184,000 | $15.04 | $2,767,360.00 | -16.9% | -33.8% | -39.0% | |
| Dec 15, 2020 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sale+OE | 134,278 | $8.32 | $1,117,192.96 | -14.6% | - | - | |
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Buy | 50,000 | $1.45 | $72,500.00 | +6.9% | - | - | |
| Dec 3, 2018 | BCRX Biocryst Pharmaceuticals Inc | President &CEO | Sale+OE | 80,000 | $9.12 | $729,600.00 | -9.9% | - | - |